Overview:

Summary

GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, Q1, 2011"" provides data on the Duchenne Muscular Dystrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Duchenne Muscular Dystrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Duchenne Muscular Dystrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Duchenne Muscular Dystrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Duchenne Muscular Dystrophy 19
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Duchenne Muscular Dystrophy Therapeutics Clinical Trials 24
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
PTC Therapeutics, Inc. 27
Clinical Trial Overview of PTC Therapeutics, Inc. 27
Santhera Pharmaceuticals Holding AG 28
Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 28
Acceleron Pharma, Inc. 29
Clinical Trial Overview of Acceleron Pharma, Inc. 29
Prosensa Therapeutics B.V. 30
Clinical Trial Overview of Prosensa Therapeutics B.V. 30
Children's Healthcare of Atlanta Inc. 31
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 31
AVI BioPharma Inc. 32
Clinical Trial Overview of AVI BioPharma Inc. 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
Assistance Publique - Hopitaux de Paris 34
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 34
Charite University 35
Clinical Trial Overview of Charite University 35
Nationwide Children's Hospital 36
Clinical Trial Overview of Nationwide Children's Hospital 36
Catholic University of the Sacred Heart 37
Clinical Trial Overview of Catholic University of the Sacred Heart 37
Imperial College London 38
Clinical Trial Overview of Imperial College London 38
Shriners Hospitals for Children 39
Clinical Trial Overview of Shriners Hospitals for Children 39
Indiana University School of Medicine 40
Clinical Trial Overview of Indiana University School of Medicine 40
Centre Hospitalier Universitaire de Nice 41
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 41
Washington University School of Medicine 42
Clinical Trial Overview of Washington University School of Medicine 42
Suzuka Kaisei Hospital 43
Clinical Trial Overview of Suzuka Kaisei Hospital 43
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 44
Clinical Trial Overview of INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 44
University of Messina 45
Clinical Trial Overview of University of Messina 45
Kumamoto University 46
Clinical Trial Overview of Kumamoto University 46
The Royal Children's Hospital 47
Clinical Trial Overview of The Royal Children's Hospital 47
Cincinnati Children's Hospital Medical Center 48
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 48
Children's Hospital Boston 49
Clinical Trial Overview of Children's Hospital Boston 49
Kobe University 50
Clinical Trial Overview of Kobe University 50
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 54"

List of Tables
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011* 11
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 17
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Duchenne Muscular Dystrophy Therapeutics Market, Global, Suspended Clinical Trials, 2011* 19
Duchenne Muscular Dystrophy Therapeutics Market, Global, Terminated Clinical Trials, 2011* 20
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 25
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 26
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by PTC Therapeutics, Inc., 2011* 27
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Santhera Pharmaceuticals Holding AG, 2011* 28
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Acceleron Pharma, Inc., 2011* 29
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Prosensa Therapeutics B.V., 2011* 30
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2011* 31
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AVI BioPharma Inc., 2011* 32
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 33
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 34
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011* 35
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2011* 36
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2011* 37
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2011* 38
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2011* 39
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2011* 40
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2011* 41
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011* 42
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Suzuka Kaisei Hospital, 2011* 43
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by INSTITUT DE RECHERCHES INTERNATIONALES SERVIER, 2011* 44
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Messina, 2011* 45
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2011* 46
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Children's Hospital, 2011* 47
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2011* 48
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2011* 49
Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2011* 50"

List of Figures
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 11
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011* 15
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 17
Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Duchenne Muscular Dystrophy  Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 26
GlobalData Methodology 52